Atlassian Shorts Edge Back as Analysts Keep Lifting Targets

TEAM is heading into its October 29 earnings report with short sellers making a modest comeback after a month of retreat, while analysts have spent the past week racing each other higher on price targets.

Short interest has crept up about 1.1% over the past week to 5.27% of free float, reversing a portion of the 7% decline recorded over the prior month. The rebound is small in absolute terms, roughly 200,000 additional shares added Monday and Tuesday, but it breaks a persistent downtrend that took short interest from above 10 million shares in mid-September to the current 8.85 million. The borrow market remains entirely unbothered: cost to borrow is 0.34%, down 5% on the week, and availability is vast at nearly 7,700% of short interest, meaning the lending pool is far from strained. No squeeze pressure exists here.

The more consequential story is the analyst community's behaviour. Nine separate firms raised price targets in the past ten days, all maintaining positive ratings. Truist lifted its Buy target to $250 from $185 on Wednesday. Citigroup moved to $245 from $225 on Tuesday. BTIG raised to $260 from $230 on Tuesday as well. Guggenheim went furthest, pushing its Buy target to $280 from $165 last Monday. The mean consensus target now stands at $222.49, just above Tuesday's close of $221.11, which by the arithmetic of consensus math implies almost no formal upside. Yet the individual targets being filed are substantially higher. The gap between a $222 mean and a cluster of $235 to $280 individual targets reflects how fast the stock has moved relative to how quickly consensus averages incorporate new revisions.

The bull case rests on Atlassian's "System of Work" platform, where Jira, Confluence, and Rovo deepen enterprise stickiness as the company pushes beyond developer workflows into broader knowledge-worker territory. Subscription ARR reached $6.6 billion, growing 23% year on year, and cloud net retention remains above 120%. The bear case is less about the platform and more about valuation and competitive pressure. The PE multiple has expanded to 34x, up more than 10% over the past month, while ServiceNow and lower-end entrants are pressing on the IT service management side. Data Center revenue is expected to fall roughly 17% in fiscal 2027 as the post-migration hangover sets in, and AI monetisation remains unproven at scale. Price-to-book has moved to 15.6x.

One structural factor worth tracking separately is Atlassian's status as a Nasdaq-100 addition candidate. ORTEX puts the probability of inclusion in the December 2026 Annual Review at 69%. The stock is currently 3.6% above the entry price line of $213.04, and with a market cap of $54.3 billion it sits comfortably above the $52.4 billion threshold. If the addition is confirmed at the December 11 announcement, index trackers would need to buy an estimated $3.1 billion worth of shares, equivalent to 3.5 days of normal trading volume, with the trade executing December 18. Among 14 comparable past additions, 79% moved in the expected direction between announcement and effective date, with a median gain of 2.1%.

Peers broadly shared in the week's gains. APPN rose nearly 15% and SPT added 12%, while GTLB and ASAN both gained 6 to 9%. TEAM's 6.3% weekly advance was modestly below that peer median of 8.4%, suggesting the stock absorbed some of the analyst-driven lift but did not lead the group. With eight days to the earnings release, the short interest rebuild, the pace of target upgrades, and the Nasdaq-100 probability are the three variables to track as the print approaches.